Cooler Heads' Amma System Gains Medical Necessity Status from Aetna for Chemotherapy Hair Preservation
In a significant breakthrough for cancer care, Cooler Heads, renowned for its innovative Amma scalp cooling system, has secured recognition from Aetna, one of America’s leading health insurers, affirming the system's medical necessity for chemotherapy patients. This landmark decision, documented in Aetna’s Clinical Policy Bulletin No. 0290, marks the beginning of a new chapter for cancer patients who wish to preserve their hair during chemotherapy treatment.
Chemotherapy is notoriously associated with hair loss, an effect that can significantly impact a patient’s emotional well-being and sense of self. For many patients, the prospect of losing their hair during treatment adds a layer of distress to an already challenging experience. However, with Aetna's endorsement, patients will now have the opportunity to benefit from a clinically supported intervention designed to alleviate this issue.
The Amma system works by cooling the scalp before, during, and after chemotherapy infusions. This cooling effect constricts blood vessels, limiting the amount of chemotherapy agents that reach the hair follicles, thus aiding in hair retention. Kate Dilligan, the founder and CEO of Cooler Heads, who has personally experienced the trials of chemotherapy, emphasizes the importance of this coverage. “Chemotherapy patients face numerous challenges during treatment. Expanding access to scalp cooling not only helps ease the financial burden but also serves a crucial role in helping patients maintain a sense of normalcy,” she stated.
Laurie Sandberg, Vice President of Market Access and Reimbursement at Cooler Heads, praised Aetna's decision as a critical advancement for cancer patients. "By expanding access to scalp cooling for their members, Aetna is addressing a vital need in cancer care and championing a standard of care that acknowledges the significant impact of hair loss on patients’ lives," she said.
This policy change is poised to enhance the quality of life for countless individuals undergoing chemotherapy. Aetna’s recognition of the Amma system signifies a pivotal shift in healthcare, positioning scalp cooling not as a cosmetic luxury, but as a medically necessary option that can drastically improve patients' conditions during a tumultuous time.
Cooler Heads, based in San Diego, CA, is committed to providing evidence-based solutions for cancer patients to manage the difficult side effects of treatment. With its mission rooted in reducing the emotional and physical toll of cancer, the company aims to empower patients through innovative tools like the FDA-cleared Amma™ System. As Aetna leads the way in this sector, more insurers may follow suit, fostering a more supportive environment for patients facing the realities of cancer treatment.
This recognition by Aetna is not just a policy shift; it's a call to action within the healthcare industry to acknowledge and support the emotional and psychological needs of patients. As healthcare providers, insurers, and pharmaceutical companies collaborate, the ultimate goal of comprehensive and compassionate cancer care becomes more achievable. Patients deserve not only to survive but to thrive, and innovations like the Amma system are pivotal in making this a reality.
Chemotherapy is notoriously associated with hair loss, an effect that can significantly impact a patient’s emotional well-being and sense of self. For many patients, the prospect of losing their hair during treatment adds a layer of distress to an already challenging experience. However, with Aetna's endorsement, patients will now have the opportunity to benefit from a clinically supported intervention designed to alleviate this issue.
The Amma system works by cooling the scalp before, during, and after chemotherapy infusions. This cooling effect constricts blood vessels, limiting the amount of chemotherapy agents that reach the hair follicles, thus aiding in hair retention. Kate Dilligan, the founder and CEO of Cooler Heads, who has personally experienced the trials of chemotherapy, emphasizes the importance of this coverage. “Chemotherapy patients face numerous challenges during treatment. Expanding access to scalp cooling not only helps ease the financial burden but also serves a crucial role in helping patients maintain a sense of normalcy,” she stated.
Laurie Sandberg, Vice President of Market Access and Reimbursement at Cooler Heads, praised Aetna's decision as a critical advancement for cancer patients. "By expanding access to scalp cooling for their members, Aetna is addressing a vital need in cancer care and championing a standard of care that acknowledges the significant impact of hair loss on patients’ lives," she said.
This policy change is poised to enhance the quality of life for countless individuals undergoing chemotherapy. Aetna’s recognition of the Amma system signifies a pivotal shift in healthcare, positioning scalp cooling not as a cosmetic luxury, but as a medically necessary option that can drastically improve patients' conditions during a tumultuous time.
Cooler Heads, based in San Diego, CA, is committed to providing evidence-based solutions for cancer patients to manage the difficult side effects of treatment. With its mission rooted in reducing the emotional and physical toll of cancer, the company aims to empower patients through innovative tools like the FDA-cleared Amma™ System. As Aetna leads the way in this sector, more insurers may follow suit, fostering a more supportive environment for patients facing the realities of cancer treatment.
This recognition by Aetna is not just a policy shift; it's a call to action within the healthcare industry to acknowledge and support the emotional and psychological needs of patients. As healthcare providers, insurers, and pharmaceutical companies collaborate, the ultimate goal of comprehensive and compassionate cancer care becomes more achievable. Patients deserve not only to survive but to thrive, and innovations like the Amma system are pivotal in making this a reality.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.